It is apparent that almost all of the major trials conducted in Africa concern infectious diseases. Lately, the incidence rates of non-communicable diseases e.g. diabetes, hypertension and many cancers are rising. Most of the therapies for these conditions are tried either in Europe or USA mainly on caucasian participants yet it is well known ethnic differences affect the pharmacokinetics and dynamics of these treatments. Shouldn't proactive efforts be instituted to make trials for investigational products for non-communicable diseases be as global as possible. What do you think?
Very timely and interesting. My personal view is that there is a dissproportionate investment in trial for infectious diseases, particularly HIV. Don't get me wrong. We of course need a HIV vaccine and good treatments however there are also children dying of poor nutrition and women in child birth. We need to work on these areas too to improve health for all
Yes Tkwahli, health for all.
CLINICAL TRIAL DIABETES. We will provide the drug and clinic HbA1c & Urinalysis machines if you can deal with local ethics & regulatory.Attached files: Diabetes_EASD_HbA1c_with_legend.jpg
We are a small voluntary research group who seek to do further clinical trials in diabetes. In Phase 2 European clinical trials, diabetics had all oral medication removed and they remained non-diabetic for 4 months. We wish to repeat these trials. If you are interested please contact me at: firstname.lastname@example.org
Thanks Dr. Richard.
Kindly check your inbox.